… by severe COVID-19, associated laboratory and clinical biomarkers of damage, severity,
and … In conclusion, the alterations found in the serum metabolome of patients with COVID-19 …

… are clinically useful in predicting a severe disease course in COVID-19 patients and to identify
… LDH and serum amyloid A (SAA) are also relevant candidate biomarkers for COVID-19. …

… biomarkers to predict severity and persistence of the disease [16,24]. Taking into account the
valuable role of biomarkers in COVID-19 … describe serum and transcriptomic biomarkers by …

… tests at determining illness severity in patients with COVID-19, biomarker levels provide
an … hold significance in assessing patient’s prognosis on admission and guiding treatment …

… To compare methods, we measured 54 serum samples from COVID-19 patients and healthy
… Analysis of IL-6 and other inflammatory biomarkers in serum of COVID-19 patients showed …

… COVID-19–related blood/serum biomarkers because previous studies on SARS-CoV have
demonstrated the importance of dynamic changes of various biomarkers and their predictive …

… biomarkers for predicting the prognosis of severe COVID-19 To identify practical prognostic
indicators in severe COVID-19 … with adverse prognosis in severe COVID-19 patients (Table 1)…

… Longitudinal serial serum samples were also collected in 56 … severity, cytokine analysis
provides additional predictive support for prognosis and likely interventions in the COVID-19 …

… among COVID-19 patients, and our findings suggest CRP could be utilized clinically to predict
COVID-19 prognosis and severity … , serum amyloid A and ferritin to predict the prognosis of …

… virus-derived factors affecting disease severity and the identification of prognostic biomarkers
and physiological processes related to COVID-19 symptomatology and relevant for the …